Keywords
Last Name
Institution

PETER JINDRA

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Surgery
DivisionSurgery-Transplant Division
Address6501 Fannin Street, Suite NA-404
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Overview 
    Collapse overview
    Dr. Peter Jindra's research interests are the role of anti-HLA antibodies in transplant rejection, the effect of single nucleotide polymorphisms on bone marrow transplant outcomes, the expression and function of microRNA in lymphocytes and murine models of transplantation.

    Collapse keywords
    • Anti-HLA antibodies
    • Hematopoietic stem cell transplantation
    • microRNA in the immune system


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU. Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2018 Apr 12; 8(1):6003. PMID: 29651104.
      View in: PubMed
    2. Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM. Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 Apr 05; 3(7). PMID: 29618661.
      View in: PubMed
    3. Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 Nov 06; 7(1):14554. PMID: 29109529.
      View in: PubMed
    4. Rana A, Kueht ML, Nicholas SK, Jindra PT, Himes RW, Desai MS, Cotton RT, Galvan NT, O'Mahony CA, Goss JA. Pediatric Liver Transplantation Across the ABO Blood Group Barrier: Is It an Obstacle in the Modern Era? J Am Coll Surg. 2016 Apr; 222(4):681-9. PMID: 27016995.
      View in: PubMed
    5. Jindra P, Raida L, Lysak D, Karas M, Papajik T, Jungova A, Mohammadová L, Houdova L. Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia. Neoplasma. 2016; 63(4):595-600. PMID: 27268923.
      View in: PubMed
    6. Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, McDermott DH, Abdi R. Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes. Biol Blood Marrow Transplant. 2016 Jan; 22(1):27-36. PMID: 26348892.
      View in: PubMed
    7. Baron F, Labopin M, Blaise D, Lopez-Corral L, Vigouroux S, Craddock C, Attal M, Jindra P, Goker H, Socié G, Chevallier P, Browne P, Sandstedt A, Duarte RF, Nagler A, Mohty M. Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96. PMID: 24419525.
      View in: PubMed
    8. Labopin M, Gorin NC, Polge E, Socié G, Gurman G, Gluckman E, Jindra P, Poiré X, Schäfer-Eckart K, Ruutu T, Milone G, Arcese W, Mohty M, Rocha V. A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplant. 2014 Mar; 49(3):376-81. PMID: 24241579.
      View in: PubMed
    9. Agustian PA, Bockmeyer CL, Modde F, Wittig J, Heinemann FM, Brundiers S, Dämmrich ME, Schwarz A, Birschmann I, Suwelack B, Jindra PT, Ahlenstiel T, Wohlschläger J, Vester U, Ganzenmüller T, Zilian E, Feldkamp T, Spieker T, Immenschuh S, Kreipe HH, Bröcker V, Becker JU. Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy. Transplantation. 2013 May 27; 95(10):1242-8. PMID: 23635876.
      View in: PubMed
    10. Jindra P, Muzik J, Indrak K, Zak P, Sabty FA, Kozak T, Cetkovsky P, Karas VK, Raida L, Szotkowski T. The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ? 50 years from the Czech acute leukaemia clinical register (alert). Neoplasma. 2013; 60(5):576-83. PMID: 23790178.
      View in: PubMed
    11. Lysák D, Merglová L, Navrátilová J, Svoboda T, Jindra P, Koza V. CD34? cell content in unrelated allogeneic peripheral blood stem cell grafts transported internationally. Does the inter-laboratory variability affect comparability of graft quality data? Transfus Apher Sci. 2012 Oct; 47(2):179-84. PMID: 22842107.
      View in: PubMed
    12. Jindra PT, Tripathi S, Tian C, Iacomini J, Bagley J. Tolerance to MHC class II disparate allografts through genetic modification of bone marrow. Gene Ther. 2013 May; 20(5):478-86. PMID: 22833118; PMCID: PMC3651743.
    13. Vokurka S, Koza V, Jungová A, Navrátilová J, Svoboda T, Jindra P, Steinerová K, Hrab?tová M, Výrutová R, Novák L. [The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation]. Klin Onkol. 2012; 25(1):42-6. PMID: 22348219.
      View in: PubMed
    14. Vokurka S, Koza V, Jungova A, Navratilova J, Svoboda T, Jindra P, Steinerova K, Vyrutova R. Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience. Bone Marrow Transplant. 2012 Jun; 47(6):867-8. PMID: 21874056.
      View in: PubMed
    15. Mociková H, Pytlík R, Raida L, Sýkorová A, Marková J, Král Z, Jindra P, Steinerová K, Válková V, Trnková M, Vacková B, Trnený M, Indrák K, Belada D, Mayer J, Koza V, Kozák T. [Treatment of patients with relapsed/refractory Hodgkin lymphoma]. Klin Onkol. 2011; 24(2):121-5. PMID: 21644367.
      View in: PubMed
    16. Jindra PT, Bagley J, Godwin JG, Iacomini J. Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol. 2010 Jul 15; 185(2):990-7. PMID: 20548023; PMCID: PMC3004219.
    17. Tian C, Yuan X, Jindra PT, Bagley J, Sayegh MH, Iacomini J. Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen. Clin Immunol. 2010 Aug; 136(2):174-87. PMID: 20452826; PMCID: PMC2991109.
    18. Ambruzova Z, Mrazek F, Raida L, Jindra P, Vidan-Jeras B, Faber E, Pretnar J, Indrak K, Petrek M. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Aug; 44(4):227-35. PMID: 19234509.
      View in: PubMed
    19. Jindra PT, Jin YP, Jacamo R, Rozengurt E, Reed EF. MHC class I and integrin ligation induce ERK activation via an mTORC2-dependent pathway. Biochem Biophys Res Commun. 2008 May 2; 369(2):781-7. PMID: 18312854; PMCID: PMC2376207.
    20. Jindra PT, Hsueh A, Hong L, Gjertson D, Shen XD, Gao F, Dang J, Mischel PS, Baldwin WM, Fishbein MC, Kupiec-Weglinski JW, Reed EF. Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts. J Immunol. 2008 Feb 15; 180(4):2214-24. PMID: 18250428; PMCID: PMC3883756.
    21. Jindra PT, Jin YP, Rozengurt E, Reed EF. HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway. J Immunol. 2008 Feb 15; 180(4):2357-66. PMID: 18250445.
      View in: PubMed
    22. Reischig T, Jindra P, Hes O, Svecová M, Klaboch J, Treska V. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation. Am J Transplant. 2008 Jan; 8(1):69-77. PMID: 17973956.
      View in: PubMed
    23. Jin YP, Korin Y, Zhang X, Jindra PT, Rozengurt E, Reed EF. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol. 2007 Jun 15; 178(12):7911-22. PMID: 17548629.
      View in: PubMed
    24. Little AM, Jindra P, Raffoux C. Strategies for new donor typing based on donor HLA type or donor characteristics. Tissue Antigens. 2007 Apr; 69 Suppl 1:8-9. PMID: 17445153.
      View in: PubMed
    25. Jindra PT, Zhang X, Mulder A, Claas F, Veale J, Jin YP, Reed EF. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation. 2006 Jul 15; 82(1 Suppl):S33-5. PMID: 16829793.
      View in: PubMed
    26. Lepin EJ, Zhang Q, Zhang X, Jindra PT, Hong LS, Ayele P, Peralta MV, Gjertson DW, Kobashigawa JA, Wallace WD, Fishbein MC, Reed EF. Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts. Am J Transplant. 2006 Jul; 6(7):1560-71. PMID: 16827856.
      View in: PubMed
    27. Jindra P, Koza V, Lysák D, Vozobulová V, Steinerová K. Inefficiency of high-dose G-CSF alone as second mobilization regimen in fludarabin-cyclophosphamide-treated CLL patients who failed to mobilize after chemotherapy and G-CSF. Bone Marrow Transplant. 2005 Apr; 35(7):729-30. PMID: 15785772.
      View in: PubMed
    28. Lysak D, Koza V, Steinerova K, Jindra P, Vozobulova V, Schutzova M. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment. Ann Hematol. 2005 Jul; 84(7):456-61. PMID: 15770494.
      View in: PubMed
    29. Jin YP, Jindra PT, Gong KW, Lepin EJ, Reed EF. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation. 2005 Feb 15; 79(3 Suppl):S19-21. PMID: 15699739.
      View in: PubMed
    30. Jin YP, Fishbein MC, Said JW, Jindra PT, Rajalingam R, Rozengurt E, Reed EF. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol. 2004 Apr; 65(4):291-302. PMID: 15120184.
      View in: PubMed
    31. Reddy PM, Jindra PT, Satz AL, Bruice TC. Sequence selective recognition in the minor groove of dsDNA by pyrrole, imidazole-substituted bis-benzimidazole conjugates. J Am Chem Soc. 2003 Jul 2; 125(26):7843-8. PMID: 12823002.
      View in: PubMed
    32. Jindra P, Koza V, Boudová L, Vozobulová V, Cerná K, Karas M, Lysák D, Svojgrová M. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation. Bone Marrow Transplant. 2003 May; 31(10):951-2. PMID: 12748677.
      View in: PubMed
    33. Karas M, Cerná K, Koza V, Jindra P, Vozobulová V, Schützová M. [Allogenic transplantation of bone marrow in patients with chronic myeloid leukemia 1991-1995 and 1996-1998. Experience at the Hematology-Oncology Clinic of the University Hospital in Plzen]. Vnitr Lek. 2001 Sep; 47 Suppl 1:34-9. PMID: 11693060.
      View in: PubMed
    34. Lysák D, Koza V, Jindra P, Vozobulová V, Schutzová M, Fiser J, Cerná K, Karas M, Skopek P, Svojgrová M, Vokurka S. Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplant. 2001 Apr; 27(7):723-6. PMID: 11360112.
      View in: PubMed
    35. Jindra P, Koza V, Svojgrová M, Skopek P, Vozobulová V, Schützová M. Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experience. Bone Marrow Transplant. 2000 Nov; 26(10):1138-9. PMID: 11108321.
      View in: PubMed
    36. Jindra P, Koza V, Fiser J, Vozobulová V, Svojgrová M. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications. Bone Marrow Transplant. 1999 Jul; 24(2):215-7. PMID: 10455354.
      View in: PubMed
    37. Koza V, Jindra P, Svojgrová M, Cetkovský P. Successful autologous transplantation in a patient with severe aplastic anemia (SAA). Bone Marrow Transplant. 1998 May; 21(9):957-9. PMID: 9613793.
      View in: PubMed
    38. Cetkovský P, Koza V, Jindra P, Skopek P, Svojgrová M. Individual criteria could be optimal for starting G-CSF application after autologous stem cell transplantation. Bone Marrow Transplant. 1997 Oct; 20(8):639-41. PMID: 9383226.
      View in: PubMed
    39. Jindra P, Koza V, Cetkovský P, Vozobulová V, Schützová M. Cyclophosphamide 3 g/m2 and G-CSF is an effective and safe outpatient-based PBSC mobilising regimen: a single centre experience. Bone Marrow Transplant. 1997 Jul; 20(1):91-3. PMID: 9232268.
      View in: PubMed
    JINDRA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _